Loading...
•
Dec 31, 2022
Y-mAbs Q4 2022 Earnings Report
Y-mAbs reported increased DANYELZA net revenues and progress in pipeline development.
Key Takeaways
Y-mAbs reported a net revenue increase of 228% compared to Q4 2021, driven by DANYELZA sales and license revenue. The company also implemented a restructuring plan and anticipates a reduction in annual operating expenses for 2023.
Reported record DANYELZA net revenues of $16.4 million in Q4 2022, a 31% sequential increase.
DANYELZA was conditionally approved in China, with a planned launch in the first half of 2023.
Implemented a restructuring plan with a 35% reduction in force and an anticipated 28% reduction in annual operating expenses for 2023.
Cash and cash equivalents totaled $105.8 million as of December 31, 2022, expected to support business operations into Q1 2026.
Forward Guidance
Management reiterated its 2023 financial guidance.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...